Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

pharmacotherapy 4270 > Psoriasis (Final Exam) > Flashcards

Psoriasis (Final Exam) Flashcards

(62 cards)

Start Studying
1
Q

psoriasis is a _-cell mediated inflammatory disease due to a complex interplay between genetic and environmental factors

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

the result of psoriasis is this type of skin disorder, where there is an increased cell turnover

A

hyperkeratosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the major gene locus for psoriasis

A

PSOR1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are some environmental factors that may cause psoriasis

A
  • trauma
  • stress
  • infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are some medications that may cause psoriases

A
  • beta-blockers
  • lithium
  • antimalarials
  • steroid withdrawal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the Koebner phenomenom

A

induction of psoriasis due to trauma (tattoo, sunburn)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

this type of psoriasis is associated with strep infections

A

guttate (drop-like) psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

true or false: HIV induced immune alterations may produce acute onset, severe psoriasis

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

this can be associated with psoriasis. may be severe and may lead to excoriations. antipruritic agents can be used to treat this such as hydroxyzine (Atarax) - can be sedating therefore take at night

A

itching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

this occurs in 5-20 pts with psoriasis. may be severe and psoriatic nail involvement is common. treatment is similar to RA

A

psoriatic arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

true or false: psychiatric disorders are common in people with psoriasis

A

true - depression is common due to physical appearance of plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

this may be associated with psoriasis; is a strong predictor of CVD, stroke, DM. cluster of risk factors include abdominal obesity, dyslipidemia, hypertensions, insulin resistance/glucose intolerance, prothromotic state, pro inflammatory state

A

metabolic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are some other immune-mediated disorders that may be present with psoriasis

A
  • chron’s disease
  • MS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

this is a possible comorbidity of psoriasis; cutaneous T-cell lymphoma, non-melanoma skin cancer (basal-cell carcinoma, squamous cell carcinoma)

A

malignancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

this is the most common type of psoriasis

A

plaque psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

this type of psoriasis is often preceded by a strep infection

A

guttate (drop-like) psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

this type of psoriasis spares areas commonly involved with plaque psoriasis. appears in skin fold (e.g. back of knees)

A

inverse psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

this type of psoriasis may be an emergency if generalized. pustules can merge to form “lakes of pus”

A

pustular psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

this type of psoriasis is usually life-threatening. presents with erythema, desquamation and edema

A

eryhtrodermic psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

this type of psoriasis only affects the palms of hands and soles of feet

A

palmar/plamtar psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

clinical manifestations of this type of psoriasis include:
- plaque like lesions with silvery-white, loosely adherent scales
- Auspitz sign (when scales are lifted, some lesions show fine bleeding points)
- lesions have sharply defined borders which are palpable
- lesions are bright, red/violet color
- lesions are possible on scalp, arms, legs, trunk, face, back, etc.
- can have yellowish lesions on nails
- thicker lesions on elbows and knees

A

plaque psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are some non-pharmacological tx for psoriasis

A
  • stress reduction
  • non-medicated moisturizers (fragrance free)
  • avoid irritants on skin
  • avoid skin trauma (wear loose fitting garments + SPF)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is the algorithm for treating mild-moderate psoriasis

A
  1. topical agents
  2. topical agents + phototherapy
  3. topical agent + systemic agents

(+ moisturizers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is the algorithm for moderate-severe psoriasis

A
  1. systemic agent (e.g. MTX) +/- topical agent or phototherapy; consider biologic agent esp if comorbidities
  2. more potent systemic agent or biologic agent +/- topical agent
  3. biologic agent (if not already used) +/- other agents

(+ moisturizers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
what is the potency of the following topical corticosteroids - hydrocortisone 0.5%, 1% - desonide 0.05%
low
26
what is the potency of the following topical corticosteroids - betamethasone dipropionate 0.05% cream/gel, fluocinonide 0.05%, halocinonide 0.1%
high
27
what is the potency of the following topical corticosteroids - betamethasone dipropionate 0.05% ointment, colbetasol propionate 0.05%
super high
28
what is the potency of the following topical corticosteroids - betamethasone valerate 0.05%, 0.1%, betamethasone dipropionate 0.05% lotion
medium
29
true or false: cream bases are more potent than ointment or lotions
false - ointment is the most potent
30
what potency of corticosteroid should be used for trunks, arms and legs
start with medium potency than titrate up or down as needed
31
this potency of corticosteroids is used for face and skin folds
low
32
this potency of corticosteroids is used for thicker plaques such as palms, soles and elbows
higher
33
what are some local a/e of topical corticosteroids
- skin atrophy - striae - telangiectasia (abnormal dilation of capillaries and arterioles) - steroid rosacea, acne - hypopigmentation - delayed wound healing - contact sensitization - decreased skin elasticity
34
what are some systemic a/e of topical corticosteroids
- HPA axis suppression (from potent topical steroids) - Cushing syndrome - Addisons crisis - retarded growth in children - hyperglycaemia, glaucoma, cataracts
35
this treatment option is used for mild-moderate psoriasis. normalizes keratinocyte differentiation and has anti-proliferative and anti-inflammatory effects. e.g. Tazarotene and Tretinoin
Topical retinoids
36
what are some a/e of topical retinoids
skin irritation - erythema, purities, burning (especially upon initial use)
37
which group of individuals should topical retinoids not be used in
women of childbearing age unless effective contraception is being used (teratogenic - contraindicated in pregnancy)
38
this treatment option can be sleeted as initial therapy for mild to moderate psoriasis. it enhances keratinocyte differentiation and inhibits proliferation and may be anti-inflammatory. e.g. Calcipotriol/Cacipotriene (Dovobet) and Calcitrol
vitamin D analogs
39
this can be used for mild to moderate psoriasis. is keratolytic and may have anti proliferative and anti-inflammatory effects. it is staining and has an unpleasant odour. may cause stinging or other irritation
coal tar
40
this treatment option has a direct anti-proliferative effect on epidermal keratinocytes. used only on thick plaque areas. highly irritating to normal skin. usual concentration 0.1-0.4%. SCAT has 10x higher concentrations therefore duration of application is only 20 mins - 2 hrs and normal skin should be protected using zinc oxide ring
Anthralin
41
what are the two types of phototherapy
PUVA (UVA + psoralens) UVB alone
42
is broadband or narrow band UVB preferred
narrow
43
what is the most common type of phototherapy used and why
NB-UVB because efficacious and decreased risk of cancer
44
this is a systemic therapy option for psoriasis. it is an oral retinoid. it is more potent if used with PUVA. this is teratogenic. a/e include hypervitaminosis A, hyperostosis, hyperlipidemia, increase in liver enzymes, hepatitis, leukopenia, cataracts
acitretin
45
low doses of this medication are usually used in psoriasis and is only taken once weekly
MTX
46
what are some s/e of methotrexate
hepatotoxicity, microcytic anemia, pulmonary fibrosis, severe skin reactions
47
true or false: MTX can be used in pregnancy
false
48
this medication is doses at lower doses for psoriasis. s/e include nephrotoxicity, increased BP, decreased magnesium, tremor, gum hyperplasia. numerous drug interactions. monitoring: BP, renal function, TG's, CBC, uric acid, potassium, magnesium
cyclosporine
49
these inhibit JAK1, JAK2, JAK3 and TyK2. can be taken as 5 mg BID or 11 mg daily (XR formulation therefore can't be split)
JAK inhibitors (Tofacitinib)
50
what are some side effects Tofacitinib (JAK inhibitor)
bone marrow suppression, lymphopenia, neutropenia, anemia, serious infections, CV 9 reduced HR and prolonged PR interval), GI perforations, hepatotoxicity
51
what needs to be monitored for Tofacitinib
CBC, Hb, Scr, LFT's, lipids at baseline and periodically
52
true or false: it is common for Tofacitinib to be used with other DMARDs and immunosuppressants z9e.g. cyclosporine)
false - these shouldn't be used together
53
these lead to increased intracellular cAMP, one end effect = reduced production of pro-inflammatory mediators
selective PDE-4 inhibitors
54
this is an oral selective PDE-4 inhibitor that is approved for tx of psoriasis and psoriatic arthritis
apremilast
55
this is a topical selective PDE-4 inhibitor that is an ointment approved for utopian dermatitis with limited clinical trial evidence for psoriasis
Crisaborole
56
what are some side effects common to all biologics
increased risk of infection potential risk of malignancies
57
________ have a potential risk of worsening CHF or new onset CHF
TNF-inhibitors
58
what do the following biologics target: Infliximab (Remicade), adalimumab (Humira), Etanercept (Enbrel)
TNF-alpha
59
what does the following biologic target Ustekinumab (Stelara)
IL-12 and IL-23
60
what do the following biologics target: Secukinumab (Cosentyx), Ixekizumab (Taltz), Brodalumab (Siliq) and Bimekizumab (Bimzelx)
IL-17 inhibitors
61
what do the following biologics target Guselkumab (Tremfya), tildrakizumab (Ilumya) and Risankizumab (Skyrizi)
IL-23
62

pharmacotherapy 4270 (19 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions